Data as of Dec 10
| -0.10 / -2.29%|
The 6 analysts offering 12-month price forecasts for Synergy Pharmaceuticals Inc have a median target of 10.25, with a high estimate of 25.00 and a low estimate of 8.50. The median estimate represents a +140.05% increase from the last price of 4.27.
The current consensus among 6 polled investment analysts is to Buy stock in Synergy Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.